SLP241220P55000
- 0.00
- 0.000.00%
Simulations Plus Newsroom
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?
Simulations Plus to Participate in the BTIG Digital Health Forum
Simulations Plus Initiated at Overweight by Stephens & Co.
Stephens Initiates Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $39
We Think Simulations Plus' (NASDAQ:SLP) Solid Earnings Are Understated
Simulations Plus Insider Sold Shares Worth $553,200, According to a Recent SEC Filing
Simulations Plus | 10-K: FY2024 Annual Report
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
BTIG Maintains Simulations Plus(SLP.US) With Buy Rating, Cuts Target Price to $50
William Blair Reiterates Outperform on Simulations Plus
BTIG Maintains Buy on Simulations Plus, Lowers Price Target to $50
Simulations Plus Analyst Ratings
Simulations Plus Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Revenue Results.
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $56
JMP Securities Maintains Simulations Plus(SLP.US) With Hold Rating
JMP Securities Reaffirms Their Hold Rating on Simulations Plus (SLP)
Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript Summary
Simulations Plus (SLP) Surpasses Q4 Earnings Estimates
Simulations Plus Non-GAAP EPS of $0.06 In-line, Revenue of $18.7M Misses by $1.03M